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ABSTRACT 
Descemet’s stripping automated endothelial keratoplasty (DSAEK) is a surgical technique for corneal transplantation in case of 
corneal decompensation. One of the main complications is graft detachment (GD) recoverable with Air Re-bubbling (ARB). The 
aim of this retrospective, interventional case series was to identify factors related to this complication in eyes operated for 
bullous keratopathy (BK) and Fuchs dystrophy (FD). We considered one-hundred patients who underwent DSAEK for BK or FD 
between January 2016 and October 2017 at Department of Ophthalmology, Policlinico Universitario of Bari, Italy. Studied 
parameters included physiological and pathological anamnesis of both donors and recipients and properties of donor’s 
lenticules and of the recipient’s corneas. Data was analyzed using One-way ANOVA with Tukey post hoc test and Chi-square 
test with Odds Ratio (OR) calculation. We grouped patients according to diagnosis. GD occurred in 9 eyes affected by BK and 19 
by FD (p=0.003, OR = 0.25, 95% CI, 0.098-0.62). It was recovered with ARB. In BK, ARB correlated to complicated cataract 
extraction (p=0.04, OR = 7.83, 95% CI, 1.28 – 47.98) and aphakia (p=0.026, OR = 54.38, 95% CI, 2.51 - 11.76). In FD, ARB was 
associated to donor’s death for neoplasia (p=0.06, OR= 4.04, 95% CI, 1.06 – 15.37). No other differences were found. In 
conclusion, we could hypothesize that in FD patients, donor’s cancer therapy may play a role on altered corneal fibroblast 
metabolism, activating a synergetic effect between chemotherapy and genetic alteration of FD, which may lead to an altered 
adhesion of donor’s lenticule on recipient's stroma. In BK patients, complicated cataract extraction and aphakic status of 
recipients’ eye may contribute to altered adhesion of donor’s lenticule post-DSAEK. 
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INTRODUCTION
Bullous keratopathy (BK) and Fuchs dystrophy (FD) are 
among the most common causes of corneal 
decompensation, often requiring corneal transplantation 
[1]. BK is a complication of many types of eye surgery, 
especially cataract extraction. It is characterized by 
corneal edema and stromal bubbles which cause pain 
and visual impairment [2]. Fuchs dystrophy is a bilateral 
corneal disease [3] due to an altered expression of the 
corneal endothelium-specific type VIII collagen [4, 5], 
which leads to a progressive deterioration of the 
endothelium. In earlier stages, it is characterized by 
‘guttae’, anatomic alteration of the Descemet’s 
membrane, visible as dark areas under the specular 
microscope. In the following stages, the confluence of 
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the guttae, progressive endothelial cell loss and 
impairment of their stromal drainage lead to stromal and 
epithelial edema with micro- and macrobubbles, 
associated with decreased visual acuity and pain [2, 3, 5]. 
In both cases, the gold standard of treatment is 
Descemet's stripping automated endothelial keratoplasty 
(DSAEK) [6-8]. Surgical complications occur in about 14% 
of cases and the most common one is graft detachment 
(GD), which occurs within the first days or up to six 
postoperative weeks [9, 10]. GD needs additional surgical 
treatment with surgical related risks. Air Re-Bubbling 
(ARB) is usually performed by inflating the anterior 
chamber with air to reattach corneal flap to the 
recipient's stroma [11]. 
In this study we aimed to identify factors related to GD 
after DSAEK in eyes operated for BK and FD, focusing on 
donors and recipient’s corneas properties and their 
medical history. 
 
METHODS 
In 2017, ethical committee approval for retrospective 
studies was not required by Policlinico Universitario of 
Bari. In our Department level, a generic scientific 
informed consent was obtained from all patients before 
surgery. This study was performed in compliance with 
the principles of the Declaration of Helsinki. 
We made a retrospective analysis of 59 eyes affected by 
BK and 45 eyes with FD undergoing DSAEK between 
January 2016 and October 2017 at the Eye Clinic, 
Department of Ophthalmology of the University General 
Hospital of Bari, Italy. Patients were identified by 
searching the Cornea Service of Bari Eye Clinic database.  
Data was collected including patient’s gender and age, 
corneal decompensation period, presence of 
pseudophakia, other ocular pathologies, keratometry 
(steep axis and average keratometry), pachymetry and 
possible concurrent phacoemulsification. Moreover, we 
analyzed data about thickness, endothelial cell density 
and diameter of the corneal lenticule as well as eye bank 
origin, donor’s gender and age, death cause and time 
span between death and corneal explantation. Finally, 
the occurrence of ARB, potentially repeated, was 
recorded. DSAEK was performed according to the 
standardized techniques [12], namely making a small 
corneal incision, stripping the Descemet’s membrane and 
endothelium layer, injecting the donor’s lenticule and 
positioning it with an air bubble in the anterior chamber. 
Pupillary block was prevented thanks to an inferior 
iridectomy. Then the patient was instructed to lay in a 
supine position in the following four hours. Anterior 
segment biomicroscopy and anterior segment optical 
coherence tomography (AS-OCT) were performed 1.5 
and 12 days after the operation. AS-OCT (MS-39, CSO srl, 
Scandicci (FI), Italy) investigated the presence of fluid 
between the donor’s lenticule and patient’s stroma by 
means of two-dimension 24 radial lines centered on 
corneal apex (16 millimeters [mm] length) [13]. 
GD was characterized by the presence of fluid between 
the transplanted lenticule and the recipient cornea 
(Figure 1). It was immediately treated by introducing an 
air bubble in the anterior chamber called ARB and 
spreading out the lenticule to attach it to the recipient’s 
underlying layers (Figures. 2 and 3). 
 
Figure 1: Graft Detachment at 1.5 days after Descemet's Stripping Automated 
Endothelial Keratoplasty. Anterior segment optical coherence tomography 
(ASOCT) (MS-39, CSO srl, Scandicci (FI), Italy) 
 
 
Figure 2: Graft repositioning with ARB at 1.5 days after Descemet's Stripping 
Automated Endothelial Keratoplasty. Anterior segment optical coherence 
tomography (ASOCT) (MS-39, CSO srl, Scandicci (FI), Italy) 
 
Figure 3: Anterior segment optical coherence tomography (ASOCT; MS-39, CSO 
srl, Scandicci (FI), Italy) at 12 days after Air rebubbling for management of post 
Descemet's Stripping Automated Endothelial Keratoplasty graft detachment. 
DSAEK was associated to cataract extraction and 
posterior chamber Intra-Ocular Lens (PC-IOL) 
implantation in 67.8% eyes affected by FD, while it was 
associated with anterior chamber IOL (AC-IOL) explant 
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and Retropupillary Iris fixated Phakic IOL implant 
(Verisyse, J&J Vision, USA) in 8.5% of eyes affected by BK. 
Data was analyzed by One-way ANOVA with Tukey post 
hoc test (p<0.05) and Chi-square test with Odds Ratio 
calculation, GraphPad InStat (GraphPAd Software Inc. 
San Diego, The USA). 
 
RESULTS 
According to corneal pathology, we categorized patients 
in two groups: BK and FD. BK group included 59 patients, 
59 eyes and FD group 41 patients, 45 eyes. 
Demographic information of patients in the both groups 
are resumed in Table 1. The groups were comparable 
regarding patient age, gender distribution and the time 
between diagnosis of corneal decompensation and 
surgery. The mean ages ± standard deviation (SD) were 
68.86±11.63 years (range, 38 to 87 years) in BK and 
70.51±9.08 years (range, 47 to 86 years) in FD (p=0.43, 
95% CI, -2.52 – 5.81). The gender distributions 
(male/female) were 29/30 in BK and 24/21 in FD (p=0.82, 
OR= 0.85, 95% CI, 0.39 – 1.8). The mean corneal 
decompensation period ± SD were 11.92±14.79 months 
(range: 1-84) in BK and 14.11±13.35 months (range: 2-72) 
in FD (p=0.49, 95% CI, -3.65 – 7.59). 
All eyes underwent corneal topography and pachymetry, 
preoperatively (Sirius CSO, Scandicci (FI), Italy). 
Topographic data are summarized in Table 2. 
 
 
Table 1: Demographic Information of Eyes Affected by Bullous Keratopathy and Corneal Fuchs Dystrophy. 
 Bullous Keratopathy Fuchs Dystrophy 
Eyes 59 45 
Age (Y); Mean ± SD, range 68.86±11.63, 38-87 70.51±9.08, 47-86 
Male/Female  29/30 24/21 
Corneal decompensation period (months); mean ±SD, range) 11.92±14.79,  1-84 14.11±13.35, 2-72 
Abbreviations: SD: standard deviation; Y: years. 
 
Table 2: Topographic Data of Both Study Groups; Bullous Keratopathy and Corneal Fuchs Dystrophy, Preoperatively. 
Recipients data: 
mean ± SD, (range) 
Bullous Keratopathy (n=59) Fuchs dystrophy (n=45) P (95% CI, range) 
Mean K: D 
 
43.47±2.73 (33.99-48.74) 44.01±2.38 (40.86-55.86) 0.29 (-0.48 – 1.56) 
Max K: D 45.49±2.77 (41.61-54.53) 
 
44.95±2.59 (41.41-58.24) 
 
0.31 (-1.06 – 0.51) 
 
White to White: mm 11.63±0.53 (10.18-12.8) 11.59±0.44 (10.5-12.9) 0.74 (-0.23 – 0.16) 
 
 CCT: µm 838.15±192.08 (511-1388) 691.24±99.53 (545-1201) <0.0001 (-209.29– 84.53) 
Abbreviations: SD: standard deviation; D: diopter; n: number; P: p-value; CI: confidence interval; Max: maximum; K: Keratometry reading; mm: 
millimeter; CCT: Central Corneal Thickness; µm: micrometer. P-value<0.05 is bold. 
 
Table 3: Clinical Data Analysis of Bullous Keratopathy Versus Fuchs Dystrophy. 
Ocular comorbidities OR 95% CI P 
Viral or bacterial keratitis 11.03 30.7-39.65 <0.0001 
Corneal edema induced by lens phacoemulsification 383.78 21.96–6707.3 <0.0001 
Surgical aphakia 5.64 0.28-112.05 0.02 
Complicated cataract surgery 11.06 0.61-201.78 0.03 
Abbreviations: OR: odds ration; CI: confidence interval; P: p-value. P-value<0.05 is bold. 
As shown in Table 2, the two groups were comparable in 
mean corneal power (Mean K), maximum corneal power 
(Max K) and White-to-White diameter. The Mean K ± SD 
were 43.47±2.73 D (range: 33.99-48.74) in BK and 
44.01±2.38 D (range 40.86-55.86) in FD (p=0.29, 95% CI, -
0.48 – 1.56). The Max K ± SD were 45.49±2.77 D (range 
41.61-54.53) in BK and 44.95±2.59 D (range 41.41-58.24) 
in FD, (p=0.31, 95% CI, -1.06 – 0.51). White-to-White 
diameters ± SD were 11.63±0.53 mm (range: 10.18-12.8) 
in BK and 11.59±0.44 mm (range: 10.5-12.9) in FD 
(p=0.74, 95% CI, -0.23 – 0.16). A significant difference 
was found in recipients’ central corneal thickness (CCT): 
BK corneas were thicker than FD ones. The mean CCT ± 
SD were 838.15±192.08 µm (range: 511-1388) in BK and 
691.24±99.53 µm (range: 545-1201) in FD (p<0.0001, 
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95% CI, -209.29 – 84.53).  Clinical data are resumed in 
Table 3.  
There was a significant stronger association of BK, rather 
than FD, with ocular comorbidities such as viral or 
bacterial keratitis (p<0.0001, OR=11.03, 95% CI, 30.7–
39.65), hard-to-overcome corneal edema induced by lens 
phacoemulsification (p<0.0001, OR=383.78, 95% CI, 
21.96–6707.3), surgical aphakia (p=0.02, OR=5.64, 95% 
CI, 0.28–112.05) and complicated cataract surgery 
(p=0.03, OR=11.06, 95% CI, 0.61–201.78). DSAEK was 
combined to lens phacoemulsification and PCIOL implant 
in all eyes affected by FD and only in 13 eyes affected by 
BK (p<0.0001, OR=0.03, 95% CI, 0.01–0.11). BK was 
related to AC-IOL, consequent to complicated cataract 
extraction in 5 eyes. It was treated with AC-IOL 
extraction, retropupillary iris-fixated Phakic IOL (Verisyse, 
J&J Vision, The USA) implant and DSAEK. 
Furthermore, we considered donors’ corneal parameters. 
The two groups were comparable in donor's whole 
corneal-stromal diameter, corneal thickness, endothelial 
cell density and diameter of implanted lenticule. The 
mean whole corneal-stromal diameter ± SD were 
9.87±0.84 mm (range: 9-11) in BK and 9.82±0.83 mm 
(range: 9-11) in FD (p=0.41, 95% CI, -17.44 – 7.2). The 
mean corneal thickness ± SD were 99.46±36.32 µm 
(range: 43-285) in BK and 104.58±23.37µm (range: 62-
154) in FD (p=0.86 (95% CI-49.11 – 41.05). The mean 
endothelial cell density ± SD were 2608±111.86 cell/mm2 
(range: 2300-2800) in BK and 2604±118.62 cell/mm2 
(range: 2300-2800) in FD (p=0.74, 95% CI, -0.38–0.27). 
The mean diameter of implanted lenticule ± SD were 
8.05±0.34 mm (range: 6.5-8.5) in BK and 8.07±0.2 mm 
(range: 7.5-8.25) in FD (p=0.78, 95% CI, -0.97 – 0.13). 
BK eyes received younger corneas than those implanted 
in FD. The mean donor age ± SD were 65.68±8.66 years 
(range: 42-79) in BK and 61.69±10.26 years (range: 36-
79) in FD (p=0.03, 95% CI, -0.3–7.67). The two groups 
were comparable in donors’ fatal disorders ratio. We 
found vascular disorders BK/FD= 12/13 (p=0.36, OR=0.63, 
95% CI, 0.25–1.55); neoplasia BK/FD=40/28 (p=0.68, 
OR=1.28, 95% CI, 0.57–2.88); respiratory disorders 
BK/FD=7/2 (p=0.19, OR=0.15, 95% CI, 0.01–3.12); 
trauma: only 2 cases in FD group. Donor gender 
distribution was similar in both groups: Male/Female 
ratio were 42/17 in BK and 23/22 in FD (p=0.04, OR=2.36, 
95% CI, 1.05–5.32). The time lap between death and 
corneal tissue explant was similar for both groups (BK: 29 
hours, FD: 21 hours; p=0.37, 95% CI, -1.28–3.43). There 
was no significant difference between the two groups in 
terms of donor corneas bank origin (Centro 
Conservazione Cornee “Piero Perelli” [Azienda USL n. 2, 
Ospedale Campo di Marte, Lucca, Italy] or Fondazione 
Banca degli Occhi del Veneto ONLUS [Zelarino (VE), 
Italy]). Lucca provided 29 corneas in BK and 21 in FD, 
while Mestre provided 30 corneas in BK and 24 in FD 
(p=0.84, OR=1.1, 95% CI, 0.51- 2.4). ARB was performed 
in 9 eyes affected by BK and in 19 affected by FD 
(p=0.003, OR= 0.25, 95% CI, 0.098–0.62). The mean time 
between surgery and ARB ± SD were 8±12.14 days 
(range: 0-32) for BK and 4.95±7.15 days (range: 1-32) for 
FD (p=0.41, 95% CI, -4.42 –10.53).  Limiting our analysis 
to patients who underwent ARB showed that BK eyes 
received thicker tissues than FD ones. The mean donor 
corneal thickness ± SD were 778.89±196.04 µm (range: 
547-1213) in BK and 665.89±61.34 µm (range: 573-786) 
in FD (p=0.03, 95% CI, -221.91–13.08). The mean± SD 
corneal decompensation period before surgery were 
12.11±11.67 months (range: 1-36) in BK and 15.53±12.76 
months (range: 4-60) in FD (p=0.5, 95% CI, -6.93–13.76). 
Aphakia was an exclusive concomitant eye disorder in BK 
eyes (p=0.02, OR=21, 95% CI, 0.95-463.4). In BK, ARB was 
associated to complicated cataract extraction (p=0.04, 
OR=7.83, 95% CI, 1.28–47.98) and aphakia (p=0.026, 
OR=54.38, 95% CI, 2.51-11.76) (Table 4). In FD, ARB was 
slightly associated to fatal disorder of donor patient, in 
particular to neoplasia (p=0.06, OR=4.04, 95% CI, 1.06–
15.37) (Table 5). 
DISCUSSION 
Statistical analysis of early GD rate in our study 
establishes the need of post-DSAEK ARB in about 28% of 
treated eyes, 16.4% of BK and 42.2% of FD. This finding 
confirms the literature data reporting mean GD rate as 
14% [9, 10], or in a range of 4-27% [11, 14]. Focusing on 
BK group, our data confirmed a higher risk of GD in case 
of aphakia or in complicated cataract extraction. In 
literature the role of glaucoma in GD is controversial [15-
18]. As recorded in recent studies by Pavlovic et al. [17], 
our data do not correlate GD to glaucoma both in BK and 
FD. Other investigated parameters (Tables 4, 5) did not 
correlate with GD in both groups, except for lenticules, 
explanted from patients affected by neoplasia, in FD 
where ARB was more frequent (42.2%) than in BK 
(15.2%). Demsey [19] demonstrated that graft dislocation 
is not influenced by variation in donor tissue processing 
and storage times. This evidence was extended to precut 
Eye Bank tissue thanks to Dapena et al. [14]. We 
excluded the influence on GD of time lapse between 
donor death and tissue implantation. A histopathological 
study of detached and failed graft conducted by Alkatan 
et Al., reported a higher risk of GD in case of irregular or 
thick graft, graft-host interface fibrous/epithelial 
ingrowth and interface infection [20]. Due to 
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retrospective limitation of our study we could consider 
only the thickness of lenticules, as recorded by Eye Bank 
data forms. For both groups thickness of lenticules was 
similar, avoiding any interference related to tissue 
preparation. Moreover, ARB was successful and 
recovered GD in all cases, excluding any further 
postoperative analysis. We did not perform venting 
incision to prevent any postoperative complication in 
patients discharged the day after surgery. Even if venting 
incisions could improve the adherence of donor's 
lenticule [21], it might increase the risk of deep infectious 
keratitis [22] or induce corneal irregular astigmatism 
[23]. Mohebbi assumed that venting incision may not be 
necessary in the standard DSAEK procedures [24] we 
refrain to proceed with this technique. Anterior segment 
biomicroscopy did not reveal any sign of graft failure or 
graft rejection prior or after ARB [25, 26]. 
 
 
Table 4: Comparative Table Between Successful Implant and Air Rebubbling in Eyes Affected by Bullous Keratopathy Following Descemet's Stripping 
Automated Endothelial Keratoplasty.  
 Air Re-Bubbling  
n or mean±SD (range) 
Successful 
n or mean±SD (range) 
Statistic 
p (95% CI) 
Records 9 50  
Age(Y) 72.67±13.81 (51-87) 68.18±11.21 (38-87) 0.29 (-3.93 – 12.09) 
M/F 2/7 27/23 0.15, OR 0.24 (0.05 – 1.29) 
Patient Cornea 
Mean K (D) 
Max K (D) 
White to White (mm) 
Thickness (µm) 
Edema onset (months) 
 
42.98±3.81 (33.99-46.92) 
46±2.51 (42.19-49.93) 
11.62±0.54 (10.6-12.4) 
778.89±196.04 (547-1213) 
12.11±11.67 (1-36) 
 
43.58±2.54 (36.83-48.74) 
45.4±2.83 (41.61-54.53) 
11.63±0.53 (10.18-12.8) 
848.82±191.4 (511-1388) 
11.88±15.39 (1-84) 
 
0.57 (-1.42 – 2.57) 
0.55 (-2.62 – 1.42) 
0.95 (-0.38 – 0.4) 
0.32 (-69.32 – 209.19) 
0.97 (-11.05 – 10.59) 
Concomitant eye pathology 
Cornea 
Glaucoma 
Retinal disorder 
Complicated cataract 
Pseudophakia 
Aphakia 
7 
3 
1 
0 
3 
0 
3 
37 
23 
7 
4 
3 
0 
0 
1, OR 1.23 (0.23 – 6.69) 
0.72, OR 0.59 (0.13 – 2.61) 
1, OR 0.77 (0.08 – 7.12) 
1, OR 0.54 (0.03 – 10.97) 
0.04, OR 7.83 (1.28 – 47.98) 
- 
0.026 OR: 54.38 (2.51 -  11.76.8) 
Combined Surgery 
Phaco + IOL implant 
IOL explant + IOL implant 
 
4 
0 
 
9 
5 
 
0.09 OR: 3.64 (0.81 – 16.33) 
1 OR: 0.43 (0.02 – 85.56) 
Donor Cornea 
Diameter of cut tissue (mm) 
Thickness (µm) 
Endothelial cell count (/mm2) 
Diameter of implanted tissue (mm) 
 
10.19±0.97 (9-11) 
95±28.97 (45-135) 
2577.78±120.19 (2400-2700) 
8.±0.25 (7.5-8.25) 
 
9.81±0.81 (9-11) 
100.26±37.68 (43-285) 
2614.26±110.68 (2300-2800) 
8.06±0.36 (6.5-8.5) 
 
0.22 (-0.98 – 0.23) 
0.69 (-21.27 – 31.78) 
0.38 (-45.03 – 117.47) 
0.63 (-0.19 – 0.31) 
Donor Patient 
Age(Y) 
M/F 
Death pathology 
     Vascular Disorders 
     Cancer 
     Respiratory Disorders 
     Trauma 
Time of death to explant (hours) 
Lucca (L) Eye Bank (tissues) 
Mestre (M) Eye Bank (tissues) 
 
70.78±6 (60-78) 
7/2 
 
2 
6 
1 
0 
8.28±5.9 (3-21.5) 
4 
5 
 
64.76±8.79 (42-79) 
35/15 
 
10 
34 
6 
0 
9.19±5.56 (2.5-23.5) 
25 
25 
 
0.05 (-12.15 – 0.11) 
1 OR: 1.5 (0.28 – 8.08) 
 
1 OR: 1.14 (0.2 – 6.37) 
1 OR: 0.94 (0.21 – 4.25) 
1 OR: 0.91 (0.1 – 8.67) 
 
0.65 (-3.15 – 4.98) 
 L versus M: 1 OR: 0.8 (0.19 -  
3.33) 
Sex Match 
Pt M –donor M 
Pt F –donor F 
 
Pt M – donor F 
Pt F – donor M 
 
 
1 
1 
 
1 
6 
 
19 
7 
 
8 
16 
 
0.5 OR: 0.37 (0.02 – 6.73) 
 
 
0.64 OR: 0.33 (0.03 – 3.26) 
 
Abbreviations: n: number; SD: Standard Deviation; CI: Confidence Interval; P: p-value; Y: year; M: male; F: female; Max: maximum; K: keratometry 
reading; D: diopter; mm: millimeter; µm: micrometer; /mm2: cells per millimeter square; OR: odds ratio; Phaco: phacoemulsification; IOL: intraocular 
lens; Pt: patient. 
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Table 5: Comparative Table Between Successful Implant and Air Rebubbling in Eyes Affected by Fuchs Dystrophy Following Descemet's Stripping 
Automated Endothelial Keratoplasty.  
 Air Re-Bubbling  
n or mean±SD (range) 
Successful 
n or mean±SD (range) 
Statistic 
p (95% CI) 
Records 19 27  
Age(Y) 73.32±7.76 (55-85) 68.46±9.56 (47-86) 0.07 (-10.24 – 0.53) 
M/F 8/11 16/7 0. 21, OR 0.32 (0.09 – 1.14) 
Patient Cornea 
Mean K (D) 
Max K (D) 
White to White (mm) 
Thickness (µm) 
Edema onset (months) 
 
43.85±1.81 (40.86-46.5) 
44.80±1.89 (41.41-47.3) 
11.46±0.36 (10.5-12.12) 
665.89±61.34 (573-786) 
15.53±12.76 (4-60) 
 
44.13±2.76 (41.26-55.86) 
45.05±30.3 (41.54-58.24) 
11.69±0.47 (10.8-12.9) 
709.77±117.82 (545-2101) 
13.08±13.92 (2-72) 
 
0.7 (-1.18 – 1.75) 
0.76 (-1.35 – 1.83) 
0.08 (-0.03 – 0.49) 
0.14 (-15.9 – 103.65) 
0.55 (-10.64 – 5.74) 
Concomitant eye pathology 
Cornea 
Glaucoma 
Retinal disorder 
Complicated cataract 
Pseudophakia 
Aphakia 
3 
2 
0 
1 
0 
0 
0 
5 
1 
1 
3 
0 
0 
0 
1, OR 0.82 (0.17 – 3.96) 
0.56, OR 3.06 (0.26 – 36.44) 
1, OR 0.45 (0.02 – 11.73) 
0.63, OR 0.44 (0.04 – 4.63) 
- 
- 
- 
Combined Surgery 
Phaco + IOL implant 
IOL explant + IOL implant 
 
13 
0 
 
24 
0 
 
0.13 OR: 0.27 (0.06 – 1.27) 
Donor Cornea 
Diameter of cut tissue (mm) 
Thickness (µm) 
Endothelial cell count (/mm2) 
Diameter of implanted tissue (mm) 
 
9.86±0.9 (9-11) 
105.32±26.42 (62-149) 
2605.26±131.12 (2300-2800) 
8.09±0.15 (7.75-8.25) 
 
9.78±0.79 (9-11) 
104.04±21.39 (68-154) 
2603.85±111.29 (2400-2800) 
8.05±0.22 (7.5-8.5) 
 
0.75 (-0.59 – 0.43) 
0.85 (-15.66 – 13.1) 
0.97 (-74.45 – 71.61) 
0.46 (-0.16 – 0.07) 
Donor Patient 
Age (Y) 
M/F 
Death pathology 
     Vascular Disorders 
     Cancer 
     Respiratory Disorders 
     Trauma 
Time of death to explant (hours) 
Lucca (L) Eye Bank (tissues) 
Mestre (M) Eye Bank (tissues) 
 
63.74±9.37 (39-74) 
9/10 
 
4 
15 
0 
0 
8.26±6 (2.5-22.5) 
10 
9 
 
60.19±10.8 (36-79) 
14/13 
 
9 
13 
2 
2 
11.48±6.66 (2.5-3) 
11 
16 
 
0.26 (-9.77 – 2.68) 
1 OR: 0.84 (0.26 – 2.71) 
 
0.51 OR: 0.53 (0.14 – 2.08) 
0.06 OR: 4.04 (1.06 – 15.37) 
0.5 OR: 0.26 (0.02 – 5.77) 
0.5 OR: 0.26 (0.02 – 5.77) 
0.1 (-0.67 – 7.1) 
 L versus M: 0.55 OR: 0.62 (0.19 -  
2.02) 
Sex Match 
Pt M –donor M 
Pt F –donor F 
 
Pt M – donor F 
Pt F – donor M 
 
3 
5 
 
5 
6 
 
8 
4 
 
8 
6 
 
0.36 OR: 0.3 (0.05 – 1.9) 
 
 
 
0.7 OR: 0.62 (0.13 – 30.7) 
Abbreviations: n: number; SD: Standard Deviation; CI: Confidence Interval; P: p-value; Y: year; M: male; F: female; Max: maximum; K: keratometry reading; D: 
diopter; mm: millimeter; µm: micrometer; /mm2: cells per millimeter square; OR: odds ratio; Phaco: phacoemulsification; IOL: intraocular lens; Pt: patient. P-
value<0.05 is bold. 
 
The exclusion of those risk factors in FD enhanced the 
correlation between lenticules explanted from patients 
affected by neoplasia and GD. This evidence points 
toward a causative relationship between the FD 
physiopathology and GD. Assuming that we did not find 
historical evidence of congenital corneal disorder, FD is 
an autosomal dominant disease that affects deeper 
corneal layers collagen [27] that are partially stripped in 
DSAEK and partially prepared to attach to graft. DSAEK 
technique realizes the stripping of the Descemet-
Endothelium complex. Probably the deeper stroma next 
to Descemet’s membrane is the weak link in graft 
adhesion, due to its anatomical and functional damage 
[28, 29]. Many reports have studied the effect of 
chemotherapy for different type of cancer on systemic 
tissues, especially on connective layers, inducing 
jeopardized disorders [30-33]. Along this evidence we 
suppose that chemotherapy affects donor’s corneal 
stroma, interfering with fibroblastic metabolism [34]. 
This feature is not relevant in BK but could be critical on 
corneas affected by congenital and metabolic disorders 
as in FD, increasing the risk of GD [3, 35, 36]. Due to our 
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limited access to donors’ clinical history, we do not have 
any data about neither donors’ neoplasia nor related 
chemotherapy.  
Strengths of the study included homogeneous sample 
and experienced single-surgeon (G.A.). Our data are 
limited by the retrospective design of the study. We 
considered ARB and anatomical recovery of GD in BK and 
FD. Histopathologic examination of donor’s detached 
lenticule was not performed because in all eyes GD was 
totally recovered by ARB. Long-term postoperative 
functional and anatomical evaluation was not recorded 
because patients were discharged immediately after 
surgery and followed by territorial ophthalmic offices. 
Therefore, future studies by eliminating these limitations 
could be more informative and valuable. 
CONCLUSIONS 
Although this study showed a complete and easy graft re-
attachment with ARB, it might expose patients to further 
risks. A desirable outcome would be identification of the 
risk factors of GD to limit further surgical approaches. We 
found that, as widely reported in the literature, aphakia 
and complicated cataract extraction increase the risk of 
GD in BK. To our knowledge for the first time we 
identified that graft explanted from neoplastic donor 
may impair DSAEK in FD, increasing GD rate of 2.6.  
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